Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ViaCyte, Inc.

http://www.viacyte.com/

Latest From ViaCyte, Inc.

Finance Watch: Insilico Raises $255m To Take AI-Discovered Drugs Into The Clinic

Private Company Edition: Nine new venture capital mega-rounds include Insilico’s series C, $250m from Blackstone for a CAR-T therapy spinout from Intellia and a $210m series B round for Umoja.

Financing Innovation

Dealmaking Quarterly Statistics, Q1 2021: Boston Scientific, Roche Start The Year With Billion-Dollar-Plus Acquisitions

During the first quarter, medical device company mergers and acquisition totalled $10.2bn, while in vitro diagnostic firms and research tools players completed M&A activity that totaled $5bn.

M & A Deals

Recall Of Cordis Stent System High-Risk Class I, US FDA Says

The Precise PRO Rx US Carotid System was yanked from shelves because the device could separate during use.

Recalls Safety

Cardinal Agrees To Sell Cordis For $1Bn To Hellman & Friedman

Cardinal said it remains “committed to its medical distribution and global medical products businesses” despite the divesture of Cordis.

Financing Cardiovascular
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
  • Medical Devices
    • Implantable Devices
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Drug Discovery Tools
      • ADMET
  • Other Names / Subsidiaries
    • BetaLogics Internal Venture
UsernamePublicRestriction

Register